Scott Holbrook is an accomplished professional with over twenty-five years of experience in molecular imaging and therapeutics, specializing in all phases of radiopharmaceutical drug development. Currently serving as the Chief Commercial and Manufacturing Officer at Ratio Therapeutics and an Advisor at PharmaLogic, they also hold positions as Co-Founder at Invivo Molecular Imaging and Precision Nuclear LLC, Chairman of the Board at Nusano, and Board Advisor at Cardiovascular Associates of America. Additionally, Scott contributes their expertise as an Adjunct Assistant Professor in the Department of Radiology at the University of Utah. Scott earned a Bachelor of Science in Clinical Nuclear Medicine from Wheeling Jesuit and a Master of Science in Molecular Imaging and Therapy from Regis College, and has authored over 100 presentations and publications in the field.
This person is not in the org chart
This person is not in any teams
This person is not in any offices